Adult outpatients with unspecified community-acquired pneumonia (CAP) rarely receive diagnostic testing for blastomycosis, coccidioidomycosis, or histoplasmosis, however repeat visits seem to drive this testing, according to a retrospective study of commercial insurance claims published in JAMA Network Open. Among 573,994 CAP patients seen from 2017–2023, only 5% underwent diagnostic testing for blastomycosis, coccidioidomycosis, or histoplasmosis, and those tests typically occurred after a median of 3 patient visits. Of those tested, 3% received a fungal disease …
Read More